• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对用于制备物理稳定纳米混悬液的不同表面改性剂进行系统筛选。

Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.

作者信息

Lestari Maria L A D, Müller Rainer H, Möschwitzer Jan P

机构信息

Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Freie Universität Berlin, Berlin, Germany; Department of Pharmaceutics, Universitas Airlangga, Surabaya, Indonesia.

出版信息

J Pharm Sci. 2015 Mar;104(3):1128-40. doi: 10.1002/jps.24266. Epub 2015 Jan 28.

DOI:10.1002/jps.24266
PMID:25630623
Abstract

The role of a surface modifier is important in the formation of stable nanosuspensions. In this study, a simple and systematic screening method for selecting optimum surface modifiers was performed by utilizing a low-energy wet ball milling method. Nine surface modifiers from different classes with different stabilization mechanisms were applied on six different models of active pharmaceutical ingredients (API). Particle size analysis showed that at concentration five times higher than the critical micelle concentration, SDS and sodium cholate (anionic surfactant) showed the highest percent success to produce stable nanosuspensions with particle size smaller than 250 nm. Similar findings were also shown by poloxamer 188 (nonionic surfactant) and hydroxypropylmethylcellulose E5 (polymeric stabilizer) at concentration 1% (w/v) and 0.8% (w/v), respectively. In addition, combinations of anionic surfactant and nonionic surfactant as well as combinations of anionic surfactant and polymeric stabilizer showed high percent success in the formation of stable nanosuspensions. In general, no correlation can be found between the physicochemical characteristics of the model API (molecular weight, melting point, log P, pKa, and crystallinity) with its feasibility to be nanosized. The concentration and the principle of stabilization of surface modifier determine the formation of stable nanosuspensions.

摘要

表面改性剂在稳定纳米混悬液的形成过程中起着重要作用。在本研究中,通过利用低能湿球磨法,进行了一种简单且系统的筛选方法来选择最佳表面改性剂。将九种来自不同类别、具有不同稳定机制的表面改性剂应用于六种不同的活性药物成分(API)模型。粒度分析表明,在浓度高于临界胶束浓度五倍时,十二烷基硫酸钠(SDS)和胆酸钠(阴离子表面活性剂)在制备粒径小于250 nm的稳定纳米混悬液方面成功率最高。泊洛沙姆188(非离子表面活性剂)和羟丙基甲基纤维素E5(聚合物稳定剂)在浓度分别为1%(w/v)和0.8%(w/v)时也显示出类似结果。此外,阴离子表面活性剂与非离子表面活性剂的组合以及阴离子表面活性剂与聚合物稳定剂的组合在形成稳定纳米混悬液方面成功率较高。总体而言,模型API的物理化学特性(分子量、熔点、log P、pKa和结晶度)与其纳米化可行性之间未发现相关性。表面改性剂的浓度和稳定原理决定了稳定纳米混悬液的形成。

相似文献

1
Systematic screening of different surface modifiers for the production of physically stable nanosuspensions.对用于制备物理稳定纳米混悬液的不同表面改性剂进行系统筛选。
J Pharm Sci. 2015 Mar;104(3):1128-40. doi: 10.1002/jps.24266. Epub 2015 Jan 28.
2
Systematic Screening of Different Surface Modifiers for the Production of Physically Stable Nanosuspensions.用于制备物理稳定纳米混悬液的不同表面修饰剂的系统筛选
J Pharm Sci. 2015 Mar;104(3):1128-1140. doi: 10.1002/jps.24266. Epub 2016 Jan 8.
3
Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?纤维素聚合物与阴离子表面活性剂的组合是否是确保BCS II类药物纳米混悬液物理稳定性的良好策略?
Pharm Dev Technol. 2016;21(4):499-510. doi: 10.3109/10837450.2015.1022788. Epub 2015 Mar 16.
4
Thermodynamics of aggregate formation between a non-ionic polymer and ionic surfactants: An isothermal titration calorimetric study.非离子聚合物与离子表面活性剂之间聚集体形成的热力学:等温滴定量热研究。
Int J Pharm. 2017 Jan 10;516(1-2):131-143. doi: 10.1016/j.ijpharm.2016.10.053. Epub 2016 Oct 24.
5
Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.确定通过湿磨介质技术制备的纳米混悬剂制剂的药物/稳定剂性质与关键质量属性(CQAs)之间的相关性。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):142-52. doi: 10.1016/j.ejps.2012.10.004. Epub 2012 Oct 22.
6
Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development.API 纳米混悬剂的喷雾干燥:干燥温度、基质形成剂的类型和含量以及粒径对成功制剂和工艺开发的重要性。
Eur J Pharm Biopharm. 2020 Jul;152:63-71. doi: 10.1016/j.ejpb.2020.04.021. Epub 2020 May 4.
7
Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property.固体纳米混悬液在纳米分散和固化过程中的可成形性研究:I. 稳定剂/药物性质的新作用。
Int J Pharm. 2013 Sep 15;454(1):269-77. doi: 10.1016/j.ijpharm.2013.06.050. Epub 2013 Jul 3.
8
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.咪康唑纳米混悬剂:制剂变量对粒径减小和物理稳定性的影响。
Int J Pharm. 2010 Aug 30;396(1-2):210-8. doi: 10.1016/j.ijpharm.2010.06.020. Epub 2010 Jun 19.
9
Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.湿磨灰黄霉素纳米混悬剂的多面特性研究,阐明其聚集状态和稳定机制。
AAPS PharmSciTech. 2018 May;19(4):1789-1801. doi: 10.1208/s12249-018-0993-4. Epub 2018 Mar 30.
10
Development of a Robust Method for Simultaneous Quantification of Polymer (HPMC) and Surfactant (Dodecyl β-D-Maltoside) in Nanosuspensions.一种用于同时定量纳米混悬液中聚合物(羟丙基甲基纤维素)和表面活性剂(十二烷基β-D-麦芽糖苷)的稳健方法的开发。
AAPS PharmSciTech. 2016 Oct;17(5):1182-91. doi: 10.1208/s12249-015-0451-5. Epub 2015 Dec 3.

引用本文的文献

1
The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate.制造工艺对微晶长效注射剂稳定性的影响:以阿立哌唑一水合物为例
Pharmaceutics. 2025 Jun 3;17(6):735. doi: 10.3390/pharmaceutics17060735.
2
Transformation of ABT-199 Nanocrystal Suspensions into a Redispersible Drug Product-Impact of Vacuum Drum Drying, Spray Drying and Tableting on Re-Nanodispersibility.ABT-199纳米晶体悬浮液向可再分散药物产品的转化——真空转鼓干燥、喷雾干燥和压片对再纳米分散性的影响
Pharmaceutics. 2024 Jun 8;16(6):782. doi: 10.3390/pharmaceutics16060782.
3
Utilizing Molecular Simulations to Examine Nanosuspension Stability.
利用分子模拟研究纳米混悬液的稳定性。
Pharmaceutics. 2023 Dec 28;16(1):0. doi: 10.3390/pharmaceutics16010050.
4
Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method.通过湿磨法筛选合适稳定剂以制备物理稳定的卡格列净纳米混悬液的系统研究
Bioengineering (Basel). 2023 Aug 4;10(8):927. doi: 10.3390/bioengineering10080927.
5
Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers.聚合物阳离子脂双层囊泡及其基于质粒 DNA 的复合物作为基因传递载体的稳定性。
Drug Deliv. 2023 Dec;30(1):2219420. doi: 10.1080/10717544.2023.2219420.
6
The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution.工艺和制剂参数对依法韦仑纳米混悬液制备的影响,以提高药物溶解度和溶出度。
Iran J Pharm Res. 2022 Sep 23;21(1):e129409. doi: 10.5812/ijpr-129409. eCollection 2022 Dec.
7
The Promising Role of Chitosan-Poloxamer 188 Nanocrystals in Improving Diosmin Dissolution and Therapeutic Efficacy against Ferrous Sulfate-Induced Hepatic Injury in Rats.壳聚糖-泊洛沙姆188纳米晶体在改善地奥司明溶解及对硫酸亚铁诱导的大鼠肝损伤的治疗效果方面的潜在作用。
Pharmaceutics. 2021 Dec 5;13(12):2087. doi: 10.3390/pharmaceutics13122087.
8
Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation.用于口服给药的载诺氟沙星脂质聚合物杂化纳米颗粒:制备、表征、计算机模拟及毒性评估
Pharmaceutics. 2021 Oct 6;13(10):1632. doi: 10.3390/pharmaceutics13101632.
9
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation.通过纳米晶体制剂的合理工艺设计克服布洛芬的溶解度障碍
Pharmaceutics. 2020 Oct 14;12(10):969. doi: 10.3390/pharmaceutics12100969.
10
Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.湿法制粒技术制备药物纳米晶体的设计空间与质量源于设计方法
Pharmaceutics. 2018 Jul 25;10(3):104. doi: 10.3390/pharmaceutics10030104.